In this study, we demonstrated the therapeutic effects of CTRP1 in improving glucose homeostasis and preventing HFD-induced obesity, hyperglycemia, insulin resistance, and fatty liver in multiple metabolic disorder models. This evidence concerns the gene C1QTNF1 and Other metabolic disease.